rs851845

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.1777+27786T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.596 in 152,118 control chromosomes in the GnomAD database, including 27,799 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.60 ( 27799 hom., cov: 34)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.00

Publications

2 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.683 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.1777+27786T>C
intron
N/ANP_054860.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.1777+27786T>C
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000636870.1
TSL:5
n.1639+27786T>C
intron
N/A
CNTNAP2
ENST00000637825.1
TSL:5
n.1260+27786T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.596
AC:
90598
AN:
151996
Hom.:
27765
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.445
Gnomad AMI
AF:
0.805
Gnomad AMR
AF:
0.629
Gnomad ASJ
AF:
0.626
Gnomad EAS
AF:
0.494
Gnomad SAS
AF:
0.701
Gnomad FIN
AF:
0.627
Gnomad MID
AF:
0.665
Gnomad NFE
AF:
0.672
Gnomad OTH
AF:
0.587
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.596
AC:
90683
AN:
152118
Hom.:
27799
Cov.:
34
AF XY:
0.594
AC XY:
44180
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.445
AC:
18464
AN:
41498
American (AMR)
AF:
0.630
AC:
9627
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.626
AC:
2173
AN:
3472
East Asian (EAS)
AF:
0.494
AC:
2548
AN:
5158
South Asian (SAS)
AF:
0.703
AC:
3389
AN:
4822
European-Finnish (FIN)
AF:
0.627
AC:
6623
AN:
10560
Middle Eastern (MID)
AF:
0.667
AC:
196
AN:
294
European-Non Finnish (NFE)
AF:
0.672
AC:
45683
AN:
67998
Other (OTH)
AF:
0.590
AC:
1246
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1911
3822
5732
7643
9554
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
764
1528
2292
3056
3820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.639
Hom.:
23045
Bravo
AF:
0.586
Asia WGS
AF:
0.592
AC:
2061
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.42
DANN
Benign
0.27
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs851845; hg19: chr7-147210919; API